CVS HEALTH Corp
CVSAPI behind this page
CVS Q2 2025 request
Playground key active
/api/financials?ticker=CVS&year=2025&quarter=2
Pick an endpoint and run the request.Income Statement
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Product | 60,607 | 56,212 | +7.8% |
| Service | 3,626 | 3,961 | -8.5% |
| Premiums Earned Net | 34,195 | 30,667 | +11.5% |
| Net Investment Income | 487 | 394 | +23.6% |
Show Business Segments breakouts |
|||
| Corporate/ Other | 83 | 96 | -13.5% |
| Corporate/ Other · Corporate/ Other | 83 | 96 | -13.5% |
| Health Care Benefits | 407 | 300 | +35.7% |
| Health Care Benefits · Operating Segments | 407 | 300 | +35.7% |
| Health Services | -3 | -2 | -50.0% |
| Health Services · Operating Segments | -3 | -2 | -50.0% |
| Revenue | 98,915 | 91,234 | +8.4% |
Show Business Segments breakouts |
|||
| Corporate/ Other · Corporate/ Other | 96 | 111 | -13.5% |
| Health Care Benefits · Intersegment Elimination | -20 | -18 | -11.1% |
| Health Care Benefits · Operating Segments | 36,258 | 32,475 | +11.6% |
| Health Services · Intersegment Elimination | -6,338 | -3,479 | -82.2% |
| Health Services · Operating Segments | 2,180 | 2,674 | -18.5% |
| Health Services · Operating Segments | 19,611 | 17,651 | +11.1% |
| Health Services · Operating Segments | 24,665 | 21,848 | +12.9% |
| Health Services · Operating Segments | 46,453 | 42,171 | +10.2% |
| Pharmacy & Consumer Wellness · Intersegment Elimination | -11,115 | -9,864 | -12.7% |
| Pharmacy & Consumer Wellness · Operating Segments | 33,581 | 29,838 | +12.5% |
Show Consolidation Items breakouts |
|||
| Intersegment Elimination | -17,473 | -13,361 | -30.8% |
| Operating Segments and Corporate/ Other | 116,388 | 104,595 | +11.3% |
| Cost of Revenue | 54,005 | 49,998 | +8.0% |
Show Business Segments breakouts |
|||
| Health Services · Operating Segments | 43,080 | 38,765 | +11.1% |
| Pharmacy & Consumer Wellness · Operating Segments | 27,554 | 23,835 | +15.6% |
| Policyholder Benefits And Claims Incurred Net | 31,317 | 27,853 | +12.4% |
Show Business Segments breakouts |
|||
| Corporate/ Other · Corporate/ Other | 40 | 46 | -13.0% |
| Health Care Benefits · Operating Segments | 30,740 | 27,458 | +12.0% |
| Health Services · Operating Segments | 1,101 | 791 | +39.2% |
| Other Cost And Expense Operating | 11,212 | 10,338 | +8.5% |
| Total Costs & Expenses | 96,534 | 88,189 | +9.5% |
| Operating Income | 2,381 | 3,045 | -21.8% |
| Interest Expense | 763 | 732 | +4.2% |
| Other Non-Operating Income (Expense) | -29 | -24 | -20.8% |
| Income Before Taxes | 1,647 | 2,337 | -29.5% |
| Income Tax Expense (Benefit) | 634 | 569 | +11.4% |
| Net Income | 1,013 | 1,768 | -42.7% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | -8 | -2 | -300.0% |
| Parent | 1,021 | 1,770 | -42.3% |
| Retained Earnings | 1,021 | 1,770 | -42.3% |
| Net Income Loss Attributable To Noncontrolling Interest | 8 | 2 | +300.0% |
| Net Income | 1,021 | 1,770 | -42.3% |
| EPS (Basic) | 0.81 | 1.41 | -42.6% |
| EPS (Diluted) | 0.8 | 1.41 | -43.3% |
| Wtd Avg Shares (Basic) | 1,266 | 1,256 | +0.8% |
| Wtd Avg Shares (Diluted) | 1,270 | 1,259 | +0.9% |
| Comprehensive Income | 1,234 | 1,792 | -31.1% |
| Net Income Loss Available To Common Stockholders Basic | 1,021 | 1,770 | -42.3% |
Balance Sheet
| Metric | Q2 2025 | Q2 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 11,787 | 12,507 | -5.8% |
| Short-Term Investments | 2,386 | 3,755 | -36.5% |
Show Total Investments [Axis] breakouts |
|||
| Debt securities available for sale | 2,251 | 3,604 | -37.5% |
| Mortgage loans | 135 | 151 | -10.6% |
| Accounts Receivable | 40,651 | 32,385 | +25.5% |
| Inventory | 17,447 | 16,068 | +8.6% |
| Other Assets Current | 3,378 | 5,237 | -35.5% |
| Total Current Assets | 75,649 | 69,952 | +8.1% |
| Non-Current Assets | |||
| Long Term Investments | 29,858 | 25,028 | +19.3% |
Show Total Investments [Axis] breakouts |
|||
| Debt securities available for sale | 24,303 | 20,227 | +20.2% |
| Mortgage loans | 1,376 | 1,251 | +10.0% |
| Other Investments | 4,179 | 3,550 | +17.7% |
| Operating Lease Right-of-Use Assets | 15,512 | 16,901 | -8.2% |
| Goodwill | 91,203 | 91,272 | -0.1% |
| Other Non-Current Assets | 5,214 | 4,798 | +8.7% |
| Total Assets | 258,343 | 252,481 | +2.3% |
| Other Assets | |||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 12,825 | 13,032 | -1.6% |
| Intangible Assets Net Excluding Goodwill | 26,224 | 28,311 | -7.4% |
| Separate Account Assets | 1,858 | 3,187 | -41.7% |
Show Fair Value Hierarchy breakouts |
|||
| Fair Value Inputs Level1 · Fair Value Measurements Recurring | 31 | 589 | -94.7% |
| Fair Value Inputs Level1 · Fair Value Measurements Recurring | 30 | 589 | -94.9% |
| Fair Value Inputs Level1 · Fair Value Measurements Recurring | 1 | — | — |
| Fair Value Inputs Level2 · Fair Value Measurements Recurring | 1,699 | 2,549 | -33.3% |
| Fair Value Inputs Level2 · Fair Value Measurements Recurring | 1,190 | 571 | +108.4% |
| Fair Value Inputs Level2 · Fair Value Measurements Recurring | 154 | 162 | -4.9% |
| Fair Value Inputs Level2 · Fair Value Measurements Recurring | 355 | 1,816 | -80.5% |
| Fair Value Inputs Level3 · Fair Value Measurements Recurring | 1 | — | — |
| Fair Value Inputs Level3 · Fair Value Measurements Recurring | 1 | — | — |
Show Financial Instrument breakouts |
|||
| Commercial Mortgage Backed Securities · Fair Value Measurements Recurring | 3 | 3 | 0.0% |
| Domestic Corporate Debt Securities · Fair Value Measurements Recurring | 287 | 1,553 | -81.5% |
| Foreign Corporate Debt Securities · Fair Value Measurements Recurring | 38 | 199 | -80.9% |
| Residential Mortgage Backed Securities · Fair Value Measurements Recurring | 8 | 32 | -75.0% |
| US Government Agencies Debt Securities · Fair Value Measurements Recurring | 34 | 593 | -94.3% |
| US States And Political Subdivisions · Fair Value Measurements Recurring | 11 | 16 | -31.2% |
Show Balance Sheet Location breakouts |
|||
| Other Receivables · Fair Value Measurements Recurring | 127 | 49 | +159.2% |
Show Fair Value By Measurement Frequency breakouts |
|||
| Fair Value Measurements Recurring | 1,731 | 3,138 | -44.8% |
| Fair Value Measurements Recurring · Cash And Cash Equivalents | 155 | 162 | -4.3% |
| Fair Value Measurements Recurring · Common/collective trusts | 1,190 | 571 | +108.4% |
| Fair Value Measurements Recurring · Debt Securities | 386 | 2,405 | -84.0% |
| Fair Value Measurements Recurring · Other asset-backed securities | 5 | 9 | -44.4% |
| Fair Value Measurements Recurring · Separate Account Cash And Cash Equivalents | 155 | 162 | -4.3% |
| Fair Value Measurements Recurring · Separate Account Debt Security | 386 | 2,405 | -84.0% |
| Current Liabilities | |||
| Accounts Payable Trade Current | 17,258 | 14,416 | +19.7% |
| Pharmacy Claims And Discounts Payable Current | 26,338 | 24,188 | +8.9% |
| Accrued Liabilities | 23,101 | 21,163 | +9.2% |
| Other Insurance Liabilities Current | 1,088 | 1,041 | +4.5% |
| Operating Lease Liability Current | 1,906 | 1,911 | -0.3% |
| Long Term Debt And Capital Lease Obligations Current | 6,160 | — | — |
| Total Current Liabilities | 94,162 | 81,386 | +15.7% |
| Deferred Revenue (Current) | 61 | 128 | -52.3% |
| Non-Current Liabilities | |||
| Operating Lease Liabilities | 14,328 | 15,537 | -7.8% |
| Deferred Tax Liabilities | 3,603 | 4,052 | -11.1% |
| Other Insurance Liabilities Noncurrent | 4,769 | 5,039 | -5.4% |
| Other Non-Current Liabilities | 4,782 | 5,526 | -13.5% |
| Total Liabilities | 180,792 | 177,370 | +1.9% |
| Other Liabilities | |||
| Liability For Claims And Claims Adjustment Expense And Health Care Organization Accounts Payable To Third Party Payor | 15,271 | 13,885 | +10.0% |
| Short Term Borrowings | 3,040 | — | — |
| Long Term Debt And Capital Lease Obligations | 57,290 | — | — |
| Separate Accounts Liability | 1,858 | 3,187 | -41.7% |
| Stockholders' Equity | |||
| Common Stocks Including Additional Paid In Capital | 50,020 | 49,371 | +1.3% |
| Treasury Stock Common Value | -36,849 | -36,919 | +0.2% |
| Retained Earnings | 63,936 | 62,797 | +1.8% |
| Accumulated Other Comprehensive Income | 272 | -319 | +185.3% |
| Total Stockholders' Equity | 77,379 | 74,930 | +3.3% |
| Minority Interest | 172 | 181 | -5.0% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 77,551 | 75,111 | +3.2% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment Net Gain Loss Including Portion Attributable To Noncontrolling Interest | -211 | -264 | +20.1% |
| Accumulated Gain Loss Cash Flow Hedge Including Noncontrolling Interest | 224 | 236 | -5.1% |
| Accumulated Net Investment Gain Loss Including Portion Attributable To Noncontrolling Interest | 4 | -564 | +100.7% |
| Accumulated Other Comprehensive Income | 272 | -319 | +185.3% |
| Aoci Including Portion Attributable To Noncontrolling Interest | 272 | -319 | +185.3% |
| Change in discount rate on long-duration insurance reserves: | 255 | 273 | -6.6% |
| Common Stock Including Additional Paid In Capital | 50,020 | 49,371 | +1.3% |
| Noncontrolling Interest | 172 | 181 | -5.0% |
| Parent | 77,379 | 74,930 | +3.3% |
| Retained Earnings | 63,936 | 62,797 | +1.8% |
| Treasury Stock Common | -36,849 | -36,919 | +0.2% |
| Total Liabilities & Equity | 258,343 | 252,481 | +2.3% |
| Treasury Stock Common Shares | 518 | — | — |
Show Equity Components breakouts |
|||
| Treasury Stock Common | 518 | 521 | -0.6% |
| Common Stock | 18 | 18 | 0.0% |
Cash Flow Statement
| Metric | YTD Q2 2025 | YTD Q2 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Proceeds From Customers | 186,500 | 173,728 | +7.4% |
| Payments For Inventory And Prescriptions Dispensed By Retail Network Pharmacies | -101,198 | -90,845 | -11.4% |
| Payments For Insurance Benefits | -58,844 | -52,485 | -12.1% |
| Payments To Suppliers And Employees | -18,630 | -21,124 | +11.8% |
| Proceeds From Interest And Dividends Received | 972 | 839 | +15.9% |
| Interest Paid | -1,484 | -1,392 | -6.6% |
| Income Taxes Paid | -863 | -729 | -18.4% |
| Net Cash from Operations | 6,453 | 7,992 | -19.3% |
| Depreciation & Amortization | 2,325 | 2,289 | +1.6% |
Show Business Segments breakouts |
|||
| Corporate/ Other | 207 | 198 | +4.5% |
| Health Care Benefits | 824 | 789 | +4.4% |
| Health Services | 521 | 525 | -0.8% |
| Pharmacy & Consumer Wellness | 773 | 777 | -0.5% |
| Stock-Based Compensation | 262 | 270 | -3.0% |
| Gain Loss On Sale Of Business | 236 | — | — |
Show Business Segments breakouts |
|||
| Health Services · Disposal Group Disposed Of By Sale Not Discontinued Operations | 236 | — | — |
| Deferred Income Taxes And Other Items | -283 | -341 | +17.0% |
| Change in Accounts Receivable | -4,139 | 2,798 | -247.9% |
| Change in Inventory | 671 | 1,937 | -65.4% |
| Increase Decrease In Other Operating Assets | -969 | -2,241 | +56.8% |
| Change in Accounts Payable | 3,831 | 1,191 | +221.7% |
| Increase Decrease In Insurance Liabilities | -34 | 1,581 | -102.2% |
| Increase Decrease In Other Operating Liabilities | 1,758 | -2,384 | +173.7% |
| Investing Activities | |||
| Proceeds From Sale And Maturity Of Marketable Securities | 6,866 | 4,418 | +55.4% |
| Payments To Acquire Investments | -7,186 | -6,781 | -6.0% |
| Capital Expenditures | -1,350 | -1,343 | -0.5% |
| Payments To Acquire Businesses Net Of Cash Acquired | -139 | -73 | -90.4% |
| Other Investing Activities | 23 | 60 | -61.7% |
| Net Cash from Investing | -1,786 | -3,719 | +52.0% |
| Financing Activities | |||
| Proceeds From Repayments Of Commercial Paper | 921 | -200 | +560.5% |
| Repayments Of Long Term Debt | -762 | -37 | -1959.5% |
| Payments Of Dividends | -1,706 | -1,698 | -0.5% |
| Proceeds From Stock Options Exercised | 191 | 228 | -16.2% |
| Tax Withholding for Share Compensation | -125 | -176 | +29.0% |
| Proceeds From Payments For Other Financing Activities | -45 | -30 | -50.0% |
| Net Cash from Financing | -1,526 | 22 | -7036.4% |
| Other Cash Flow | |||
| Net Change in Cash | 3,141 | 4,295 | -26.9% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 12,025 | 12,820 | -6.2% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.